Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 3, 1997, Pages 1228-1234

  Cui, Lixin ^a   Locatelli, Luisa ^a   Xie, Meng Yu ^a   Sommadossi, Jean Pierre ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; DRUG METABOLITE; LAMIVUDINE; MITOCHONDRIAL DNA; NUCLEOSIDE DERIVATIVE; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; DNA CONTENT; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; DRUG METABOLISM; NERVE FIBER GROWTH; NERVE REGENERATION; NEUROTOXICITY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL;

ANIMALS; DIDANOSINE; DIDEOXYNUCLEOSIDES; DNA REPLICATION; DNA, MITOCHONDRIAL; NERVE GROWTH FACTORS; NEURITES; PC12 CELLS; PHOSPHORYLATION; RATS; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

EID: 0030981260     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. ANDERSON, S., BANKIER, A. T., BARRELL, B. G., DE BRUJIN, M. H. L., COULSON, A. R., DROUIN, J., EPERON, I. C., NIERLICH, D. P., ROE, B. A., SANGER, F., SCHREIER, P. H., SMITH, A. J. H., STADEN, R. AND YOUNG, I. G.: Sequence and organization of the human mitochondrial genome. Nature (Lond.) 290: 457-465, 1981.
2. BAILEY, R. O., BALTCH, A. L., VENKATESH, R., SINGH, J. K. AND BISHOP, M. B.: Sensory motor neuropathy associated with AIDS. Neurology 38: 886-891, 1988.
3. BALZARINI, J., HERDEWIJN, P. AND DE CLERCQ, E.: Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′ -dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J. Biol. Chem. 264: 6127-6133, 1989.
4. BROWNE, M. J., MAYER, K. H., CHAFEE, S. B., DUDLEY, M. N., POSNER, M. R., STEINBERG, S. M., GRAHAM, K. K., GELETKO, S. M., ZINNER, S. H., DENMAN, S. L., DUNKLE, L. M., KAUL, S., MCLAREN, C., SKOWRON, G., KOUTTAB, N. M., KENNEDY, T. A., WEITBERG, A. B. AND CURT, G. A.: 2′,3′-Didehydro-3'-deoxythymidine (d4T) in patients with AIDS and AIDS-related complex: A phase I trial. J. Inf. Dis. 167: 21-29, 1993.
5. CHANG, C. N., DOONG, S. L., ZHOU, J. H., BEACH, J. W., JEONG, L. S., CHU. C. K., TSAI, C. H. AND CHENG, Y. C.: Deoxycytidine deaminase-resistant steroisomer is the active form of (±)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication. J. Biol. Chem. 267: 13938-13942, 1992.
6. CHEN, C. H. AND CHENG, Y. C.: Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J. Biol. Chem. 264: 11934-11937, 1989.
7. CHEN, C. H. AND CHENG, Y. C.: The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2′,3′-dideoxycytidine. J. Biol. Chem. 267: 2856-2859, 1992.
8. CHEN, C. H., VASQUEZ-PADUA, M. AND CHENG, Y. C.: Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol. Pharmacol. 39: 625-628, 1991.
9. COOLEY, T. P., KUNCHES, L. M., SAUNDERS. C. A., RITTER, J. K., PERKINS, C. J., MCLAREN, C., MCCAFFREY, R. P. AND LIEBMAN, H. A.: Once daily-administration of 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: Results of a phase I trial. N. Engl. J. Med. 322: 1340-1345, 1990.
10. COONEY, D. A., DALAL, M., MITSUTA, H., MCMAHON, J. B., NADKARNI, M., BALZARINI, J., BRODER, S. AND JOHNS, D. G.: Initial studies on the cellular pharmacology of 2′.3′-dideoxycytidine, an inhibitor of HTLV-III infectivity. Biochem. Pharmacol. 35: 2065-2068, 1986.
11. CORNBLATH, D. R. and MCARTHUR, J. C.: Predominantly sensory neuropathy in patients with AIDS and ARC. Neurology 38: 794-796, 1988.
12. CUI, L., YOON, S., SCHINAZI, R. F. AND SOMMADOSSI, J. P.: Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodouracil in human liver cells. J. Clin. Invest. 95: 555-563, 1995.
13. DUBINSKY, R. M., YARCHOAN, R., DALAKAS, M. AND BRODER, S.: Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′-dideoxycytidine (ddC). Muscle Nerve 12: 856-860, 1989.
14. ERON, J. J., BENOIT, S. L., JEMSEK, J., MACARTHUR, R. D., SANTANA, J., QUINN, J. B., KURITZKES, D. R., FALLON, M. A. AND RUBIN, M.: Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. N. Engl. J. Med. 333: 1662-1669, 1995.
15. FARAJ, A., FOWLER, D. A., BRIDGES, E. G. AND SOMMADOSSI, J. P.: Effects of 2′,3′-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis. Antimicrob. Agents Chemother. 38: 924-930, 1994.
16. GRAY, H. AND WONG, T. W,: Purification and identification of subunit structure of the human mitochondrial DNA polymerase. J. Biol. Chem. 267: 5835-5841, 1992.
17. GRAY, N. M., MARR, C. L. P., PENN, C. R., CAMERON, J. M. AND BETHELL, R. C.: The intracellular phosphorylation of (-)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ. Biochem. Pharmacol. 50: 1043-1051, 1995.
18. GREENBEBG, M. E., GREENE, L. A. AND ZIFF, E. B.: Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC-12 cells. J. Biol. Chem. 260: 14101-14110, 1985.
19. GREENE, L. A., ALETTA, M., RUKENSTEIN, A. AND GREEN, S. H.: PC-12 pheochromocytoma cells: Culture, nerve growth factor treatment, and experimental exploitation. Methods Enzymol. 147: 207-216, 1987.
20. GREENE, L. A. AND TISCHLER, A. S.: PC12 pheochromocytoma cultures in neurobiology research. Adv. Cell Neurobiol. 3: 373-414, 1982.
21. HAROUSE, J. M., KUNSCH, C., HARTLE, H. T., LAUGHLIN, M. A., HOXIE, J. A., WIGDAHL, B. AND GONZALEZ-SCARANO, F: CD4-indepedent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63: 2527-2533, 1989.
22. INSDORF, N. F. AND BOGENHAGEN, D. F.: DNA polymerase γ from Xenopus laevis. J. Biol. Chem. 264: 21498-21503, 1989.
23. KAGUNI, L. S. AND OLSON, M. W.: Mismatch-specific 3′→5′ exonuclease associated with the mitochondrial DNA polymerase from Drosophila embryos. Proc. Natl. Acad. Sci. USA 86: 6469-6473, 1989.
24. KEILBAUGH, S. A., PRUSOFF, W. H. AND SIMPSON, M. V.: The PC-12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs. Biochem. Pharmacol. 42: R5-R8, 1991.
25. KLECKER, R. W. JR., COLLINS, J. M., YORCHOAN, R., THOMAS, R., MCATEE, N., BRODER. S. AND MYERS, C. E.: Pharmacokinetics of 2′,3′-dideoxycytidine in patients with AIDS and related disorders. J. Clin. Pharmacol. 28: 837-842, 1988.
26. KUNKEL, T. A. AND MOSBAUGH, D. W.: Exonucleolytic proofreading by a mammalian DNA polymerase γ. Biochemistry 28: 988-995, 1989.
27. LAMBERT, J. S., SEIDLIN, M., REICHMAN, R. C., PLANK, C. S., LAVERTY, M., MORSE, G. D., NVUPP, C., MCLAREN, C., PETTINELLI, C. AND VALENTINE, F. T.: 2′,3′-Dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: A phase I trial. N. Engl. J. Med. 322: 1333-1340, 1990.
28. MARTIN, J. L., BROWN, C. E., DAVIS, N. M. AND REARDON, J. E.: Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob. Agents Chemother. 38: 2743-2749, 1994.
29. MERIGAN, T. C., SKOWRON-, G., BOZZETTE, S. A., RICHMAN, D., UTTAMCHANDANI, R., FISCHL, M., SCHOOLEY, R., HIRSCH, M., SOO, W. AND PETTINELLI, C.: Circulating p24 antigen levels and responses to dideoxycytidine in HIV infections. A phase I and II study. Ann. Intern. Med. 110: 189-194, 1989.
30. MITSUYA, H., YARCHOAN, R. AND BRODER, S.: Molecular targets for AIDS therapy Science 249: 1533-1544, 1990.
31. PARKER, W. B. AND CHENG, Y. C.: Mitochondrial toxicity of antiviral nucleoside analogs. J. NIH Res. 6: 57-61, 1994.
32. PARRY, G.: Peripheral neuropathies associated with HIV infection. Ann. Neurol. 23: S49-S53, 1988.
33. PEZESHKPOUR, G., KRARUP, C., BUCHTHAL, F., DIMAURO, S., BRESOLIN, N. AND MCBURNEY, J.: Peripheral neuropathy in mitochondrial disease. J. Neurol. Sci. 77: 285-304, 1987.
34. RIOPELLE, R. J. AND KENNEDY, J. C.: Some aspects of porphyrin neurotoxicity in vitro. Can. J. Physiol. Pharmacol. 60: 707-714, 1982.
35. RUBENSTEIN, R. AND PRICE, R. W.: Replication of thymidine kinase deficient herpes simplex virus type 1 in neuronal cell culture: Infection of the PC-12 cell. Arch. Virol. 78: 49-64, 1983.
36. SIMPSON, D. L., DICKENS, G., DOLL, S., KOIZUMI, S., TOCCO, M., OKUDA, O., OSHIMA, M., RUDKIN, B. B., BRIGHTMAN, M. AND GUROFF, G.: Differentiation of PC12 ' cells with K-ras: Comparison with nerve growth factor. J. Neurosci. Res. 28: 486-496, 1991.
37. SO, Y. T., HOLTZMAN, D. M., ABRAMS, D. I. AND OLNEY, R. K: Peripheral neuropathy associated with acquired immunodeficiency syndrome. Arch. Neurol. 45: 945-948, 1988.
38. SOMMADOSSI, J. P.: Nucleoside analogs: Similarities and differences. Clin. Inf. Dis. 16: S7-S15, 1993.
39. STEVENSON, M. A., CALDERWOOD, S. K. AND COLEMAN, C. N.: Effects of nitroimidazoles on neuronal cells in vitro. Int. J. Radiat. Oncol. Biol. Phys. 16: 1225-1230, 1989.
40. YARCHOAN, R., PLUDA, J. M., THOMAS, R. V., MITSUYA, H., BROUWERS, P., WYVILL, D. M., HARTMAN, N., JOHNS, D. G. AND BRODER, S.: Long term toxicity/activity profile of dideoxyinosine in AIDS or ARC. Lancet 336: 526-529, 1990.
41. ZHU, Z., HITCHCOCK, M. J. M. AND SOMMADOSSI, J. P.: Metabolism and DNA interaction of 2′,3′-didehydro-2′,3′-dideoxythymidine in human bone marrow cells. Mol. Pharmacol. 40: 838-845, 1991.